The tal-l gene, frequently activated in human T-cell acute lymphoblastic leukemia (T-ALL), is expressed in the erythroid, megakaryocytic, and mast cell lineages during normal hematopoiesis. To gain further insight into the molecular mechanisms that control tal-l expression, we investigated tal-l chromatin structure in erythroidlmegakaryocytic cell lines and in T-cell lines either with or without tal-1 rearrangements. Tal-l transcription was shown to be monoallelic in Jurkat, a T-cell line that expresses tal-l in the absence of apparent genomic alteration of the locus. Methylation studies indicated that the tal-l 5' GC-rich region behaves like a CpG island, hypomethylated in normal cells, and methylated de novo on transcriptionally inactive alleles HE TAL-l GENE (also called SCL) was initially identified because of its involvement in t( l ; 14) translocations associated with T-cell acute lymphoblastic leukemia (T-ALL).'-3 The tal-l protein possesses a basic-helix-loophelix domain, and therefore belongs to a family of proteins involved in the control of cell growth and differentiation and associated with le~kemogenesis.~,~ During normal hematopoiesis, tal-l gene expression is restricted to the erythroid, megakaryocytic, and mast cell lineage^.^.' In leukemic T cells, its expression is often linked to chromosomal rearrangements. These rearrangements are the most frequent chromosomal abnormalities associated with T-ALL, since they affect approximately 30% of patients with childhood T-ALL.8 Furthermore, they appear to be highly specific of this disease, since tal-l rearrangements have not been observed in other types of leukemias or lymphomas, except in one case of B-ALL.9"3
HE TAL-l GENE (also called SCL) was initially identified because of its involvement in t( l ; 14) translocations associated with T-cell acute lymphoblastic leukemia (T-ALL).'-3 The tal-l protein possesses a basic-helix-loophelix domain, and therefore belongs to a family of proteins involved in the control of cell growth and differentiation and associated with le~kemogenesis.~,~ During normal hematopoiesis, tal-l gene expression is restricted to the erythroid, megakaryocytic, and mast cell lineage^.^.' In leukemic T cells, its expression is often linked to chromosomal rearrangements. These rearrangements are the most frequent chromosomal abnormalities associated with T-ALL, since they affect approximately 30% of patients with childhood T-ALL.8 Furthermore, they appear to be highly specific of this disease, since tal-l rearrangements have not been observed in other types of leukemias or lymphomas, except in one case of B-ALL.9"3
The most common tal-l rearrangement (12% to 25% of T-ALL patients) is a submicroscopic 90-kb deletion (tal-l d) juxtaposing the first exons of the SIL gene to the 5' noncoding part of tal-l transcription nit.^"^.'^.'^ An additional 3% of T-ALL patients present a t(1;14) (p32;qll) translocation.I6 In most of the cases, the recombination implicates lp32 breakpoints clustered within a l-kb segment flanking tal-l exon 3, and 14qll breakpoints in the TCRS locus. These translocations result in the positioning of the D6 region to the 5' side of tal-l coding This type of t(1; 14) translocation is associated with a high level of tall transcription, presumably initiating within the D6 r e g i~n . '~ Thus, in rearrangements affecting the 5' part of tal-l locus, the transcription initiation is clearly driven from promoters active in the T-cell lineage and brought in the 5' vicinity of tal-l transcription unit. This mechanism might also explain the recently reported case of a T-ALL that displayed a translocation t( 1;3)(p34;p21) involving a chromosome 1 breakpoint located 10 kb 5' of tal-l first exon, and a novel transcription unit on chromosome 3, active in the T-cell lineage.I8 In two cases of t(1; 14) translocation that affected the 3' proximal region of tal-l locus and the D6 region, tal-1 transcription was shown to be initiated within tal-l fourth exon." More distal 3' breakpoints have been reported in two additional cases of T-ALL."," Although the consequences of these distal rearrangements on tal-l transcription have not been explored, they suggest that tal-l activation might be mediated by long range cis-activating mechanisms. These 3' alterations of tal-1 locus, either proximal or more distal, raise the question of which DNA regions within the tal-l locus mediate the transcriptional response to the T-lymphoid regulatory elements translocated on chromosome 1. Finally, it has been reported that several established T-cell lines and blasts from T-ALL patients express high levels of tal-l transcripts in the absence of any apparent tal-l genomic altera t i~n . '~. '~ It is presently unknown whether tal-l transcription in such leukemic T cells reflects an activation in trans of both alleles or a cis activation of a single allele.
The molecular mechanisms that control tal-l expression in its germline configuration (ie, in the erythroid and megakaryocytic lineages) and in T-ALL devoid of 5' alterations of the locus are so far poorly understood. Two promoters, l a and lb, are located in the 5' region of the tal-l gene, and a third promoter is located within tal-l fourth exon. The promoter 1 a is active only in cells of the erythroid and megakaryocytic lineages, whereas the promoter l b is active both in these cells and in leukemic T cells without evident genomic alterations of tal- 1 The promoter located in exon 4 is active in leukemic T cells either with or without obvious alterations of the locus, but not in normal bone marrow or in established cell lines of the erythroidmegakaryocytic lineages." Apart from the three promoters mentioned above, no regulatory sequences have been identified in this transcriptionally complex locus. In a first attempt to define the regulatory elements that control tal-l expression, we investigated tal-l chromatin structure (as probed by its methylation status and hypersensitivity to DNase-I) in erythroidlmegakaryocytic cell lines, and in different T-cell lines expressing tal-l gene with or without any reported structural alteration of the locus. In this report, we show that tal-l transcription is monoallelic in Jurkat T-cell line, that tal-l 5' GC rich region behaves like a CpG island, and that the preferential use of the different tal-] promoters, ie, promoters l a and l b in erythroidlmegakaryocytic cell lines, promoter 1 b in Jurkat, and promoter exon 4 in DU528, is associated with specific DNase-I hypersensitive sites (HS) located in the 5' region of tal-l locus.
MATERIAL AND METHODS
Tissues and cell lines. Human cell lines were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (HELA) or in RPM1 supplemented with 10% (HEL, K562, JURKAT, PEER, HUT78) or 20% (DU.528) fetal calf serum, Lglutamine, penicillin, and streptomycin (Gibco BRL, Gaithersburg, MD). Normal human dermic fibroblasts were a gift of Latifa Hila1 (INSERM U 91, Crkteil, France). Monocytes cells were a gift of S. Lachance (INSERM U 91, Crkteil, France). Peripheral blood lymphocytes were isolated from peripheral blood by Ficoll-Paque density centrifugation.
Polymerase chain reaction ampliJication, cDNA synthesis, and sequence analysis. Primers specific for the 5' part of tal-l exon 6 (5' GGCGTATCTTCACCAACAGC 3' and 5' ATTCTCACCCCA-CCTGCCCT 3') correspond to sequences located between nucleotides 779 to 798 and 1275 to 1294 (according to Bernard et all2) and specifically amplify a 514-bp fragment. Reactions were performed according to the manufacturer instructions (Perkin Elmer, Roche Molecular Systems, Branchburg, NJ). Sequence analysis was performed directly on the polymerase chain reaction (PCR) products or PCR fragments cloned into T-vectors (Stratagene, La Jolla, CA), using a Taq DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) and an automatic sequencer (373A apparatus; Applied Biosystems).
PolyA+ RNA was extracted from the JURKAT cell line using a QuickPrep micromRNA Purification Kit (Pharmacia, Milwaukee, WI). First-strand cDNA was synthesized in a 50-pL reaction containing 1 pg polyA+ RNA, 20 U human placenta RNAse inhibitor (Gibco BRL), 100 mmol/L Tris, pH 8. DNA extraction and Southern hybridization. DNA was extracted by proteinase K digestion (0.1 or 0.2 mg/mL) at 56°C overnight. phenol chloroform extraction, and ethanol precipitation. DNA, I O pg, was digested to completion with the indicated restriction enzymes, electrophoresed on 0.8% agarose gels, and transferred to nitrocellulose membranes (Hybond C Extra; Amersham, Les Ulis, France) by Southern blotting. Hybridization was performed with random primed "P-labeled probes at 65°C in 5 X SSC (0.6 mol/L NaCl, 0.06 mol/L Na citrate, pH 7), 1 x Denhardt's mix, 20 mmol/L NaPO.,, pH 6.7, and 10% dextran sulfate. Highest-stringency washes consisted of 0.1 X SSC and 0.1% SDS at 65°C. The genomic probes used are probe I (a 1 .S-kb MboI-XhoI fragment), probe 2 (a 2.2-kb Xhol fragment), and probe 3 (a 1.4-kb BamHI-KpnI fragment) for the methylation studies; and probe HX (a 0.5-kb XbaI-Hind111 fragment) and probe Bg-B (a I-kb BgIII-BamHI fragment) for the DNase-I studies. The location of these probes within tal-l locus is indicated in the figures.
RESULTS
Expression of the tal-l gene is monoallelic in the JURKAT T-cell line. The JURKAT T-cell line, established from a T-ALL, transcribes tal-l at high levels, although it is not associated with lp32 chromosomal alteration. By Southern blot analysis using probes encompassing 50 kb of the tal-l locus, we did not detect any genomic rearrangement (data not shown). This result, together with the fact that JURKAT transcription of tal-l was mainly initiated from the promoter lb, and to a much lesser extent from the promoter located in exon 4,19 prompted us to determine whether one or both alleles were transcriptionally active. Direct sequencing of tal-l exon 6 showed a DNA polymorphism at the nucleotide (nt) 1156 (A or G) (according to the numbering used by Bernard et all2) in Jurkat genomic DNA (Fig la) . To confirm this polymorphism, we cloned PCR products encompassing the beginning of exon 6 and sequenced several clones. Two types of subclones were obtained: one with nt 1 156 = G , as expected from published sequences, and the other with nt I156 = A (Fig lb) . PolyA+ RNA was extracted from Jurkat cells, reverse-transcribed, and the cDNA produced directly sequenced after PCR amplification. Sequences of cDNAs from Jurkat cell line or from a clonal cell population derived For personal use only. on October 22, 2017. by guest www.bloodjournal.org From from this line displayed greater than 90% incorporation of dideoxynucleotides corresponding to the normal nt 1156 G on either strands (Fig IC) . Although these data cannot formally rule out a weak transcription of the allele bearing the polymorphic nt 1156 A, they strongly suggest that tal-l transcription is consecutive to a cis-activating mechanism and most probably monoallelic in the Jurkat cell line.
Methylation status of the tal-l locus in established cell lines and in normal cells. DNA methylation on CpG has been implicated in the regulation of gene expression in mammalian ~e l l s . *~~~~ Since the 5' noncoding part of tal-l transcription unit lies in a highly G + C-rich region, we examined the methylation status of the actively transcribed tal-l gene in the erythroidmegakaryocytic cell lines HEL and K562, and in T-cell lines with or without any reported genomic alteration of the locus, as well as in T-cell lines in which the locus is silent. Genomic DNA was digested with HpaII or MspI and analyzed by Southern blotting for methylation of the tal-l gene using probes located either in the 5' region of the transcription unit, or in the exon 4 region, which is also characterized by a high GC content. Complete digestion by HpaII was attested by hybridizing the same blots with a probe located in the CpG island of the housekeeping gene, uroporphyrinogen decarboxylase (Uro-D). A detailed map of the tal-l genomic region, MspI sites, and probes used is shown in Fig 2A, and representative autoradiographs are shown in Fig 2B and C . The 5' part of tal-l locus is unmethylated in cell lines that express tal-l from the promoters l a and l b such as HEL or K562, since hybridization with probe l identified one major band of 0.8 kb and probe 2 three bands of 0.74 kb, 0.45 kb, and 0.3 kb in both MspI and HpaII digests. In T-cell lines that do not express tal-l, we did not observe these MspI-like HpaII fragments, but higher molecular weight bands (0.96 kb with probe 1, 1.6 kb with probe 2 in HUT78, 3 kb and 6 kb fragments with either probes in Peer). Therefore, this part of the locus was mildly methylated in HUT78 cells, and highly methylated in PEER cells. In JURKAT cells, the probe 1 hybridized simultaneously to a MspI-like HpaII fragment of 0.8 kb and to higher molecular weight HpaII fragments of 1.2 kb and 3 kb. The probe 2 identified three MspI-like HpaII fragments of 0.74 kb, 0.45 kb, and 0.3 kb, but also larger HpaII fragments of 1.6 kb and 3 kb. Since we showed that tal-l transcription is most probably monoallelic in JURKAT, these results suggest that the transcriptionally active allele is methylation-free, whereas the inactive allele is not. A similar pattern of HpaII digestion, characterized by the simultaneous presence of Mspl-like and larger HpaII fragments was also observed in SKW3 and Molt4, two T-cell lines reported to express tall in the absence of local genomic alteration" (and our unpublished data). Interestingly, the CEM T-cell line, which bears the SIL-tal d l type of deletion (with a tal-l breakpoint located between exons l a and lb), exhibited hypomethylation of the rearranged allele in its 5' part (the probe 1 hybridized to a rearranged MspI-like 1.1-kb HpaII fragment and to HpaII fragments of 1.2 kb, 2.4 kb, and 3 kb), whereas the downstream region appeared highly methylated (the probe 2 hybridized to 1.6-kb, 3-kb, and 6-kb HpaII fragments). The DU528 cell line is associated with a t(1; 14) affecting the 3' noncoding part of the sixth exon and has been reported to initiate tal-1 transcription exclusively within the tal-l fourth exon." Analysis of tal-l methylation status in this cell line showed a high degree of methylation in the 5' part of the locus, whereas the fourth exon initiation region is unmethylated (data not shown). In fact, the exon 4 flanking region was hypomethylated in all the cell lines we tested regardless of tal-l expression (data not shown). The methylation patterns observed in most of the cell lines studied are listed in Table 1 . Because transcription and absence of methylation seemed to be correlated, we assessed whether methylation could be involved in the repression of tal-l expression in normal tissues. We therefore explored the methylation status of the 5' GC-rich region in normal cells that do not express tal-l, ie, peripheral blood lymphocytes, leukocytes, and fibroblasts. Figure 2C clearly shows that the tal-l 5' region is methylation-free in these three tissues. Together, our results indicate that the tal-l 5' GC-rich region behaves like a CpG island: it is methylation-free in vivo, whether transcribed or not, and becomes methylated on transcriptionally inactive alleles in established cell lines.
Specific DNase4 HS are associated with the preferential use of the diferent tal-l promoters. Hypersensitivity of chromatin to DNase-I digestion has been used to identify regulatory elements of several gene^.*^-'^ To determine which regions of the tal-l locus might be implicated in the control of its expression, either in cells of the erythroid megakaryocytic lineage or in leukemic T-cell lines, we mapped DNase-I HS in 45 kb of genomic DNA encompassing the tal-l transcription unit. Figure 3 shows the mapping of DNase HS after Hind111 digestion and hybridization with a 3' HindIII-XbaI probe in HEL, K562, JURKAT, PEER, HUT78, and DU528 cell lines. In addition to the germline 20-kb fragment, several additional fragments were detected. Two fragments of 1.7 and 1.9 kb (HS Va and b) and a fragment of 4.8 kb (HS IV) were exclusively observed in HEL and K562. HS Va and Vb were more intense in K562, whereas HS IV was more intense in HEL. The probe hybridized strongly to a 11.6-kb fragment in Jurkat (HS 11). This fragment was already present, albeit more faintly, in Jurkat cells that had not been treated with DNase-I (lane 0), probably because of endogenous DNases activity. However, the intensity of this fragment augmented with increasing amounts of DNase-I, whereas the intensity of the germline fragment decreased, indicating that this region is highly sensitive to DNase-I in Jurkat. A very faint band of the same size was also detected in HEL, K562, DU528, HUT78, and Peer. An intense band of 7.8 kb (HS 111) was observed in DU528. A fragment of a similar size, but much weaker in intensity, was also observed in HEL, together with a weak 6-kb fragment. Rehybridization of the blot with a probe located in the sixth exon did not show any HS in the 3' part of the locus in HEL, K562, and Jurkat cell lines (data not shown).
To map these DNase-I HS more precisely, we used the 3' BamHI-BgIII probe on BamHI-digested DNAs (Fig 4) . In addition to the 16.5-kb germline fragment, we observed an intense 2.3 kb (HS 111) fragment in DU528, which was very weak in HEL and Jurkat lines; an intense 6.1-kb (HS 11)
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in Jurkat cells that had not been treated with DNase-I, which probably reflects the activity of endogenous DNases. HS I was not previously observed in HEL or K562 HindIII-digested DNAs, either because this site was too close to the 5' end of the germline fragment or because preferential cut- ting of DNase-I occurred in the HS IV and V regions. The
DNase sensitivity of HEL chromatin as shown by the 6-kb fragment in Hind111 digestions could not be further explored with the BurnHI digestion, since this potential DNase-I HS mapped in the region of the probe used to hybridize BurnHI blots. DNase-I treatment followed by BgIII digestions and subsequent hybridization with the 5' BgIII-BarnHI probe previously used in the BurnHI studies confirmed the presence of HS IV in HEL and indicated a weak DNase-I hypersensitivity in the promoter l b in JURKAT and in the exon 4 promoter in DU528, but did not show any other major HS (data not shown). 
DISCUSSION
Several established T-cell lines and blasts from T-ALL patients express high levels of tal-l mRNA in the absence of apparent alterations of tal-l locus. These observations suggest that tal-l expression in T-ALL could result from an activation in trans of both alleles, possibly reflecting a transitory expression of this gene during T-lymphocyte differentiation that would persist on transformation. Although thymic tal-l transcripts have not been detected by Northern blotting a n a l y s i~, '~,~~.~' a transient activation of this gene in particular stages of T-lymphocyte differentiation cannot be formally excluded in view of the following observations: (1) a faint tal-l transcription has been detected in the thymus by reverse transcriptase PCR analysis7; (2) the presence of sparse fetal and adult mouse thymic cells expressing tal-l protein has been recently reported32; (3) a cryptic tal-l promoter located within exon 4 has been shown to be exclusively active in leukemic T cells with or without tal-l genomic alterations"; and (4) since transcriptionally active loci are more likely to be targets for chromosomal rearrangements, the identification of recurrent translocations involving tal-l and TCRG loci suggests that both might be active at the same stage in early T-cell development.
As Jurkat cell line is devoid of gross genomic alterations of the locus and expresses a high level of tal-l mRNA, initiated mostly in the exon l b and to a much lesser extent in the exon 4, we investigated the transcriptional activity of both tal-l alleles in this cell line. The systematic sequencing of tal-l -transcribed regions allowed us to identify a DNA polymorphism in the coding part of the sixth exon. Within the sensitivity limits of the method we used, our data strongly suggest that tal-l transcription occurs uniquely on one allele in Jurkat cells, thus indicating a cis-activating mechanism. DNA polymorphisms such as the one reported here could be used to appreciate whether transactivation of the locus occurs in other leukemic T cells that do not display obvious structural genomic alteration. The cis-activating mechanism responsible for the tal-l monoallelic transcription in Jurkat could be either a point mutation or a long-range cis-activating rearrangement. We are currently investigating this last hypothesis.
To define the regulatory elements that control tal-l expression either in its germline configuration or in T-ALL devoid of 5' alteration of the locus, we decided to investigate tal-l methylation status and DNase-I hypersensitivity in erythroid megakaryocytic cell lines known to express tal-l from the promoters 1 a and 1 b, in Jurkat cells that express tal-1 mainly from the promoter lb, in DU528, a T-cell line bearing a t(1; 14) affecting the 3' part of tal-l transcription unit and initiating transcription within exon 4, and in PEER and HUT78 (T-cell lines that do not express tal-l gene).
CpG methylation is known to contribute to the repression of genes located on the inactive X c h r o m~s o m e~~ and has been proposed to be involved in the regulation of tissuespecific gene e x p r e s s i~n .~~~~ Analysis of tal-l 5' region and a nonhematopoietic cell line (HELA) were analyzed. JURKAT express tal-l gene in the absence of reported genomic alteration of the locus; DU528 bears a t(1;14) translocation affecting the 3' noncoding part of t a l -l transcription unit and express tal-l gene. PEER and HUT78 do not express this gene. The different fragments observed in these cell lines are indicated by arrows. methylation status in different established cell lines indicated a correlation between active transcription and hypomethylation. Yet, this correlation was not observed in normal tissues that do not express the tal-l gene. These results demonstrate that tal-l 5' region behaves like a CpG island, hypomethylated in normal cells regardless of tal-l expression, and methylated de novo on transcriptionally inactive alleles in established cell lines. It has been suggested that the methylation of CpG islands that occurs in established cell lines is incompatible with expression of the associated genes.34s3s This phenomenon is presumably linked to the alterations in chromatin structure and/or to the inhibition of binding of transcription factors, either directly or via competition with the binding of methyl CpG proteins.3639 Our data on the methylation status of tal-l 5' region in the T cell line CEM clearly showed a hypomethylation in the taldl rearranged region (encompassing SIL first exon and tal-l exon lb) and a high level of methylation downstream (in the region of tal-l exons 2 and 3), even on the transcriptionally active allele. This observation may be relevant to recent studies indicating that methylation affects the formation of the preinitiation complex rather than the elongation of transcription.40 Hypomethylation of Bcl-2 first exon has recently been proposed to be indicative of truns activation of both alleles in B-chronic lymphocytic leukemias:' The hypomethylation of tal-l gene in normal T lymphocytes that do not express tal-l precludes the utilization of this chromatin marker to evaluate tal-l monoallelic or biallelic transcription in T-ALL devoid of genomic rearrangement, but stil?indicates a potential accessibility of the tal-l locus to recombination, as recently reported for the immunoglobulin K gene DNase-I HS have been associated with a wide range of cis-regulatory sequences and are usually indicative of protein-DNA interactions." Extensive mapping of the DNase4 HS in the chromatin of several cell lines allowed us to identify five major hypersensitive sites in the 5' part of tal-l locus. These sites were absent in HELA, a carcinoma-derived cell line, suggesting their hematopoietic specificity. No HS was found in the 3' part of the locus. HS I is located 10.3 kb 5' of tal-l exon l a and was only observed in the erythroid/megakaryocytic cell lines HEL and K562. HS I1 is located 7 kb 5' of tal-l exon la, in the vicinity of the fourth tal-l breakpoint reported in SIL-tab1 deletions (d4).I4 This HS was present as a weak band in all the hematopoietic cell lines tested, independently of tal-l expression, but absent in Hela. This site might define a particular state of chromatin structure in the vicinity of tal-l locus that could play a role in the transcriptional competence of tal-l during hematopoiesis and could favor recombination events during T-cell maturation. However, this site exhibited a strong DNase-I sensitivity in Jurkat, suggesting that this DNA region might also be implicated in the cis-activation of tal-l transcription from For personal use only. on October 22, 2017. by guest www.bloodjournal.org From 3826 LEROY-VIAAD ET AL the promoter l b in this cell line. This result, together with the monoallelic expression of tal-l in Jurkat, infers that this particular region could mediate the transcriptional effects of distant DNA rearrangements, as already reported for other oncogenes such as myc or E V~I .~~.~ HS I11 was mapped 3.1 kb 5' of tal-l exon la. This site was major in DU528 and weak in HEL and Jurkat cell lines. In DU528, the activation of the exon 4 promoter was supposed to be driven by the enhancer of TCRG, positioned 3' of tal-l transcription unit by the t (1; 14) translocation. Our results suggest that the molecular mechanisms involved in the deregulation of tal-l gene expression in DU528 might be more complex than previously thought, since they might implicate three different regulatory elements: the TCRS enhancer, tal-l HS 111, and tal-l exon 4 promoter. Such complex molecular interactions (locus control region/enhancer/promoter) have already been described in the regulation of genes such as p globinz8 or CD2?7 If the monoallelic transcription of tal-l in Jurkat results from a long-distance recombination event, then the preferential activation of different HS and distinct promoters in Jurkat and DU528 should be linked either to the respective location of the different regulatory elements on the rearranged allele, or to the nature of the regulatory element brought in the vicinity of the tal-l locus by the rearrangement. HS sites IV (located in promoter la) and V (located 2.8 and 3 kb 3' of tal-l exon la, in the intervening sequences between exons 2a and 3) were observed exclusively in the erythroidmegakaryocytic cell lines. It should be pointed out that HS TV is located in the proximal region of the tissue-specific exon la. This region contains two GATA motifs and Spl consensus binding sites, and we and others have recently shown that it defines the tal-l minimal promoter in erythroid cells47 (and Lecointe et al, submitted).
Since this promoter has a relatively low activity in transient assays, we postulated that sequences outside of this region are likely to enhance its function. HS I and V might identify such regions, since they were exclusively observed in cells of the erythroidmegakaryocytic lineage. Furthermore, the close inspection of HS V sequence shows numerous GATA, SpI, and Ets binding sites within this region, supporting its role as an erythroidmegakaryocytic regulatory sequence.48
Together, our data demonstrate that the preferential use of the different tal-l promoters is linked to distinct regulatory elements revealed as strong DNase-I HS.
